Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neuropathic Pain in Multiple Sclerosis Improved With Oral Famciclovir: A Case Report.
Neuroimmunological diseases and pregnancy.
Rat Cortical Oligodendrocyte-Embryonic Motoneuron Co-Culture: An In Vitro Axon-Oligodendrocyte Interaction Model.
Risk of fractures in patients with multiple sclerosis: record-linkage study.
MicroRNAs Regulate Human Brain Endothelial Cell-Barrier Function in Inflammation: Implications for Multiple Sclerosis.
Nitric oxide inhibits CXCL12 expression in neuroinflammation.
Multiple sclerosis: Brain volume loss strengthens disease measure.
Fluoxetine prevents oligodendrocyte cell death by inhibiting microglia activation after spinal cord injury.
Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination.
Enhanced Action Potential Passage Through the Node of Ranvier of Myelinated Axons via Proton Hopping.
Opexa Therapeutics provides MS trial enrollment update; 70% of patients enrolled
Differences in oligoclonal bands and visual evoked potentials in patients with radiologically and clinically isolated syndrome.
Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture.
The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain.
Voltage-gated potassium channel antibodies: Game over.
Perception of affective prosody in patients at an early stage of relapsing-remitting multiple sclerosis.
Sleep loss as risk factor for neurologic disorders: A review.
Multiple sclerosis presenting as a relapsing amnestic syndrome.
Advances in the management of MS symptoms: real-life evidence.
Requirement for interleukin-1 to drive brain inflammation reveals tissue-specific mechanisms of innate immunity.
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment.
Treatment of multiple sclerosis in children and its challenges.
Impact of 24 Weeks of Resistance and Endurance Exercise on Glucose Tolerance in Persons with Multiple Sclerosis.
The immunogenetics of multiple sclerosis: A comprehensive review.
Neuroborreliosis during natalizumab treatment in multiple sclerosis.

Pages